Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CBHcy

Copy Product Info
🥰Excellent
TargetMol
Catalog No. T25210Cas No. 88096-02-0

CBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia.

CBHcy

CBHcy

Copy Product Info
🥰Excellent
TargetMol
Catalog No. T25210Cas No. 88096-02-0
CBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$279In StockIn Stock
5 mg$693In StockIn Stock
10 mg$988In StockIn Stock
25 mg$1,460In StockIn Stock
50 mg$1,980In StockIn Stock
100 mg$2,670In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:>99.99%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

CBHcy AI Summary
CBHcy shows strong inhibition activity against the human BHMT (Betaine-homocysteine S-methyltransferase) enzyme, demonstrated by an IC50 value of 87.0 nM. At higher concentrations, such as 1 μM and 20 μM, it exhibits potent inhibitory effects of 98.3% and 100.0%, respectively. It also displays high binding affinity to BHMT, with low Ki and Kd values under various assay conditions, indicating a robust inhibitory effect on enzyme activity..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
CBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia.
Chemical Properties
Molecular Weight235.3
FormulaC9H17NO4S
Cas No.88096-02-0
SmilesO=C(O)CCCCSCCC(N)C(=O)O
Relative Density.1.276 g/cm3 (Predicted)
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Ethanol: < 1 mg/mL (insoluble)
DMSO: < 1 mg/mL (insoluble)
H2O: < 1 mg/mL (insoluble)
0.1M HCl: 1.56 mg/mL (6.63 mM), Sonication is recommended.
Solution Preparation Table
0.1M HCl
1mg5mg10mg50mg
1 mM4.2499 mL21.2495 mL42.4989 mL212.4947 mL
5 mM0.8500 mL4.2499 mL8.4998 mL42.4989 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CBHcy | purchase CBHcy | CBHcy cost | order CBHcy | CBHcy chemical structure | CBHcy formula | CBHcy molecular weight